Announcements Trials
Browse Landscape

Phase

Phase NA 32Phase EARLY_PHASE1 2Phase 3 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 2

Conditions

Neoplasms 2

Interventions

Cyclophosphamide 5Positron Emission Tomography Computed Tomography 4pembrolizumab 3Topotecan 2Surveys and Questionnaires 2Psilocybin 2Midazolam 2Methods 2Ketoconazole 2Ketamine 2temsirolimus 1posaconazole 1poly ICLC 1parathyroid hormone-related peptide (1-36) 1lavender oil 1jojoba wax 1ginger extract 1fluoromisonidazole 1fludarabine phosphate 1fludarabine 1fluciclovine F-18 1evolocumab 1etoposide phosphate 1beta-Glucans 1Whole-Body Irradiation 1Vincristine 1Varenicline 1Transplantation 1Transcranial Direct Current Stimulation 1Tetrahydrouridine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Neoplasms × Methods × Clear all
NCT05128838 2025-02-05

RISE (Reinvent, Integrate, Strengthen, Expand) Self-Management Program for Cancer Survivors: A Feasibility Study

Cedars-Sinai Medical Center

Phase EARLY_PHASE1 Completed
23 enrolled
Tumor-Agnostic

Neoplasms

NCT01835509 2014-02-25

Group Intervention to Increase Physical Activity in Childhood Cancer Survivors

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase EARLY_PHASE1 Completed
20 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡